These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 25295466)
1. Gene therapy for hemophilia B with liver-specific element mediated by Rep-RBE site-specific integration system. Xu Z; Ye J; Zhang A; Xie L; Shen Q; Xue J; Chen J J Cardiovasc Pharmacol; 2015 Feb; 65(2):153-9. PubMed ID: 25295466 [TBL] [Abstract][Full Text] [Related]
2. A 16-bp RBE element mediated Rep-dependent site-specific integration in AAVS1 transgenic mice for expression of hFIX. Xu ZX; Chen JZ; Yue YB; Zhang JQ; Li ZH; Feng DM; Ruan ZC; Tian L; Xue JL; Wang QJ; Jia W Gene Ther; 2009 May; 16(5):589-95. PubMed ID: 19242526 [TBL] [Abstract][Full Text] [Related]
3. A 16bp Rep binding element is sufficient for mediating Rep-dependent integration into AAVS1. Feng D; Chen J; Yue Y; Zhu H; Xue J; Jia WW J Mol Biol; 2006 Apr; 358(1):38-45. PubMed ID: 16516232 [TBL] [Abstract][Full Text] [Related]
4. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors. Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450 [TBL] [Abstract][Full Text] [Related]
5. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Miao CH; Thompson AR; Loeb K; Ye X Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909 [TBL] [Abstract][Full Text] [Related]
6. [Human coagulation factor IX gene therapy in murine hemophilia B by hydrodynamic delivery and site-specific genomic integration]. Zhang L; Gu DS; DU WT; Liu PX; Lu SH; Yang RC Zhonghua Xue Ye Xue Za Zhi; 2010 May; 31(5):294-9. PubMed ID: 21122306 [TBL] [Abstract][Full Text] [Related]
7. The transient expression of mRNA coding for Rep protein from AAV facilitates targeted plasmid integration. Howden SE; Voullaire L; Vadolas J J Gene Med; 2008 Jan; 10(1):42-50. PubMed ID: 18001001 [TBL] [Abstract][Full Text] [Related]
8. Gene therapy for hemophilia B mice with scAAV8-LP1-hFIX. Lu W; Zhou Q; Yang H; Wang H; Gu Y; Shen Q; Xue J; Dong X; Chen J Front Med; 2016 Jun; 10(2):212-8. PubMed ID: 27052253 [TBL] [Abstract][Full Text] [Related]
9. Hepatic control elements promote long-term expression of human coagulation factor IX gene in hydrodynamically transfected mice. Kim HS; Kim JC; Lee YK; Kim JS; Park YS J Gene Med; 2011 Jul; 13(7-8):365-72. PubMed ID: 21710610 [TBL] [Abstract][Full Text] [Related]
10. Regulation of human factor IX expression using doxycycline-inducible gene expression system. Srour MA; Fechner H; Wang X; Siemetzki U; Albert T; Oldenburg J; Hanfland P; Poller W; Brackmann HH; Schwaab R Thromb Haemost; 2003 Sep; 90(3):398-405. PubMed ID: 12958607 [TBL] [Abstract][Full Text] [Related]
11. Roles of adeno-associated virus Rep protein and human chromosome 19 in site-specific recombination. Young SM; McCarty DM; Degtyareva N; Samulski RJ J Virol; 2000 May; 74(9):3953-66. PubMed ID: 10756007 [TBL] [Abstract][Full Text] [Related]
12. Potential limits of AAV-based gene therapy with the use of new transgenes expressing factor IX fusion proteins. Le Quellec S; Dane A; Enjolras N; McIntosh J; Rosales C; Negrier C; Nathwani A Haemophilia; 2019 Jan; 25(1):e11-e18. PubMed ID: 30520547 [TBL] [Abstract][Full Text] [Related]
13. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Miao CH; Ohashi K; Patijn GA; Meuse L; Ye X; Thompson AR; Kay MA Mol Ther; 2000 Jun; 1(6):522-32. PubMed ID: 10933977 [TBL] [Abstract][Full Text] [Related]
14. A new potent hFIX plasmid for hemophilia B gene therapy. Lee JS; Lee M; Kim SW Pharm Res; 2004 Jul; 21(7):1229-32. PubMed ID: 15290864 [TBL] [Abstract][Full Text] [Related]
15. Optimized human factor IX expression cassettes for hepatic-directed gene therapy of hemophilia B. Zhang R; Wang Q; Zhang L; Chen S Front Med; 2015 Mar; 9(1):90-9. PubMed ID: 25663062 [TBL] [Abstract][Full Text] [Related]
16. Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer. Cohn EF; Zhuo J; Kelly ME; Chao HJ J Thromb Haemost; 2007 Jun; 5(6):1227-36. PubMed ID: 17362228 [TBL] [Abstract][Full Text] [Related]
17. Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero. Schneider H; Mühle C; Douar AM; Waddington S; Jiang QJ; von der Mark K; Coutelle C; Rascher W J Gene Med; 2002; 4(1):46-53. PubMed ID: 11828387 [TBL] [Abstract][Full Text] [Related]
18. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. Grimm D; Zhou S; Nakai H; Thomas CE; Storm TA; Fuess S; Matsushita T; Allen J; Surosky R; Lochrie M; Meuse L; McClelland A; Colosi P; Kay MA Blood; 2003 Oct; 102(7):2412-9. PubMed ID: 12791653 [TBL] [Abstract][Full Text] [Related]
19. Recombinant Adeno-Associated Viral Vectors Expressing Human Coagulation FIX-E456H Variant in Hemophilia B Mice. Le Quellec S; Dane AP; Barbon E; Bordet JC; Mingozzi F; Dargaud Y; Marais T; Biferi MG; Négrier C; Nathawani AC; Enjolras N Thromb Haemost; 2019 Dec; 119(12):1956-1967. PubMed ID: 31659733 [TBL] [Abstract][Full Text] [Related]
20. Targeted introduction and effective expression of hFIX at the AAVS1 locus in mesenchymal stem cells. Li SJ; Luo Y; Zhang LM; Yang W; Zhang GG Mol Med Rep; 2017 Mar; 15(3):1313-1318. PubMed ID: 28112377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]